199 related articles for article (PubMed ID: 27826612)
21. Hydroa vacciniforme present for 48 years with cytotoxic CD4+ T-cell infiltration and Epstein-Barr virus infection.
Xie JL; Chen GY; Jin Y; Zheng XD; Wei XJ; Zheng YY; Zhang SH; Zhang YN; Zhang XJ; Zhou XG
Br J Dermatol; 2012 Feb; 166(2):449-51. PubMed ID: 21801161
[No Abstract] [Full Text] [Related]
22. EBV-associated hydroa vacciniforme-like T-cell lymphoma.
Roy SF; Ghazawi FM; Powell J; Kokta V; Bélisle A
Br J Haematol; 2019 Sep; 186(6):802. PubMed ID: 31218678
[No Abstract] [Full Text] [Related]
23. NK-/T-cell lymphoma resembling hydroa vacciniforme with positive CD4 marker expression: a diagnostic difficulty.
Zhang G; Bai HX; Yang L; Ma MH; Su Y; Luo Y; Wen H; Lu Q; Xiao R
Am J Dermatopathol; 2013 Feb; 35(1):94-7. PubMed ID: 22885552
[TBL] [Abstract][Full Text] [Related]
24. Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis.
Saleem A; Natkunam Y
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098335
[No Abstract] [Full Text] [Related]
25. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
[TBL] [Abstract][Full Text] [Related]
26. Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.
Pahlow Mose A; Fisker N; Clemmensen O; Bygum A
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422336
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γδ T cells.
Tanaka C; Hasegawa M; Fujimoto M; Iwatsuki K; Yamamoto T; Yamada K; Kawa K; Saikawa Y; Toga A; Mase S; Wada T; Takehara K; Yachie A
Br J Dermatol; 2012 Jan; 166(1):216-8. PubMed ID: 21729029
[No Abstract] [Full Text] [Related]
28. Hydroa vacciniforme-like lymphoma of an adult: a case report with review of the literature.
Wang M; Wang S; Yang QP; Liu YM; Gao LM; Sun H; Liu WP
Diagn Pathol; 2013 May; 8():72. PubMed ID: 23635342
[TBL] [Abstract][Full Text] [Related]
29. Systemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literature.
Yang YQ; Fan L; Wang L; Xu J; Zhang R; Ge Z; Li JY; Xu W
Int J Clin Exp Pathol; 2014; 7(9):6403-8. PubMed ID: 25337300
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
31. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
Chen CC; Chang KC; Medeiros LJ; Lee JY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
[TBL] [Abstract][Full Text] [Related]
32. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
[TBL] [Abstract][Full Text] [Related]
33. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
34. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
Chen CC; Chang KC; Medeiros LJ; Lee JY
J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
[TBL] [Abstract][Full Text] [Related]
35. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review.
Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z
BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.
Verneuil L; Gouarin S; Comoz F; Agbalika F; Creveuil C; Varna M; Vabret A; Janin A; Leroy D
Br J Dermatol; 2010 Jul; 163(1):174-82. PubMed ID: 20367637
[TBL] [Abstract][Full Text] [Related]
37. [Hypersensitivity to mosquito bites and hydroa vacciniforme].
Iwatsuki K; Yamamoto T; Tsuji K
Nihon Rinsho; 2006 Mar; 64 Suppl 3():657-61. PubMed ID: 16615554
[No Abstract] [Full Text] [Related]
38. An elderly patient with chronic active Epstein-Barr virus infection with severe hydroa vacciniforme-like eruptions associated with αβT-cell proliferation.
Nomura H; Egami S; Kasai H; Mori M; Yokoyama T; Fujimoto A; Sugiura M; Iwatsuki K
J Dermatol; 2014 Apr; 41(4):360-2. PubMed ID: 24628134
[No Abstract] [Full Text] [Related]
39. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
Asano N; Kato S; Nakamura S
Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
[TBL] [Abstract][Full Text] [Related]
40. An update on viral-induced cutaneous lymphoproliferative disorders. CME Part I.
Plaza JA; Gru AA; Sangueza OP; Lourenco SV; Puccio FB; Sanches JA; Miyashiro D; Toussaint S; Sangueza MJ
J Am Acad Dermatol; 2023 May; 88(5):965-980. PubMed ID: 36041557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]